Valuation : Stereotaxis, Inc.

Market Cap 139M 120M 113M 103M 193M 13.15B 193M 1.33B 517M 6.75B 523M 512M 21.74B P/E 2026 *
-6.84x
P/E 2027 * -9.48x
Enterprise Value 139M 120M 113M 103M 193M 13.15B 193M 1.33B 517M 6.75B 523M 512M 21.74B EV / Sales 2026 *
4.06x
EV / Sales 2027 * 3.05x
Free-Float
78.85%
Yield 2026 *
-
Yield 2027 * -
1 week-4.14%
Current month-3.47%
1 month-2.11%
3 months-26.06%
6 months-36.82%
Current year-39.57%
1 week 1.35
Extreme 1.35
1.49
1 month 1.3
Extreme 1.3
1.51
Current year 1.24
Extreme 1.24
2.86
1 year 1.24
Extreme 1.24
3.59
3 years 1.24
Extreme 1.24
3.59
5 years 1.24
Extreme 1.24
7.22
10 years 0.47
Extreme 0.47
10.3
Manager TitleAgeSince
Chief Executive Officer - 2017-02-02
Director of Finance/CFO 57 2019-09-30
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 79 2005-01-31
Chairman - 2017-02-02
Director/Board Member 71 2016-09-28
Date Insider Type Main position Quantity % Market Cap. Importance
7/1/26 Free

Director

43,103 0.0441%
7/1/26 Free

Director

43,103 0.0441%
7/1/26
DAFNA Capital Management LLC
OtherCompany 0 0% -
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-4.14%-49.64%-23.63% 139M
-0.75%-1.35%+25.39%+10.15% 227B
-1.60%-3.89%+4.34%-21.81% 146B
-0.85%-1.58%-19.32%+18.13% 130B
+1.81%+2.05%-55.45%-10.85% 69.27B
+0.13%-0.34%+11.04%+17.70% 51.82B
+0.49%-1.32%-17.27%-14.42% 50.45B
+0.59%-1.94%+17.42%+23.75% 42.53B
-1.01%-1.28%+36.60%+45.68% 40.22B
-1.55%+1.22%+123.40%+29.54% 32.95B
Average -0.22%-1.82%+7.65%+7.42% 78.99B
Weighted average by Cap. -0.44%-1.55%+7.63%+5.98%

Financials

2026 *2027 *
Net sales 34.33M 29.54M 27.8M 25.39M 47.5M 3.24B 47.63M 328M 127M 1.66B 129M 126M 5.36B 45.67M 39.3M 36.97M 33.77M 63.18M 4.31B 63.35M 437M 170M 2.21B 171M 168M 7.13B
Net income -20.13M -17.32M -16.3M -14.89M -27.86M -1.9B -27.93M -193M -74.74M -975M -75.6M -73.95M -3.14B -14.77M -12.71M -11.96M -10.92M -20.43M -1.39B -20.49M -141M -54.82M -715M -55.45M -54.24M -2.3B
Net Debt - -
Logo Stereotaxis, Inc.
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation (RMN), transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. Its primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, it offers its customers x-ray systems and other accessory devices. It also provides robotic technologies for interventional cardiology and neuro-interventions. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters.
Employees
131
Date Price Change Volume
26-09-04 US$1.390 0.00% 344,434
26-09-03 US$1.390 +0.72% 399,628
26-09-02 US$1.380 +0.73% 315,740
26-09-01 US$1.370 -4.86% 598,718
26-08-31 US$1.440 -0.69% 593,115
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
1.390USD
Average target price
3.000USD
Spread / Average Target
+115.83%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. STXS Stock